← All Imunon, INC filings

Imunon, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NASDAQ
IMNN
Imunon, INC
DEF: Imunon Sets June 16, 2026 Annual Meeting Date
Imunon, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 16, 2026, to elect directors, ratify auditors, and vote on executive compensation and stock incentive plan amendments.
NASDAQ
IMNN
Imunon, INC
DEF: IMUNON Seeks Shareholder Approval for Reverse Stock Split, Capital Raise, and Increased Share Authorization Amidst Nasdaq Delisting Threat
IMUNON, INC. is calling for its annual stockholder meeting on July 11, 2025, to vote on critical proposals including a reverse stock split, a significant increase in authorized shares, and the approval of shares underlying recent warrants, all aimed at addressing Nasdaq listing deficiencies and securing future funding.
NASDAQ
IMNN
Imunon, INC
DEF 14A: Imunon, Inc. Announces Details for 2024 Annual Stockholders Meeting
Imunon, Inc. will hold its annual stockholders meeting virtually on June 12, 2024, to elect directors, ratify the selection of its accounting firm, and conduct an advisory vote on executive compensation.